Sign Up to like & get
recommendations!
1
Published in 2019 at "European journal of pharmacology"
DOI: 10.1016/j.ejphar.2019.172465
Abstract: Lung adenocarcinoma (LUAD) is typically featured by a low 5-year survival rate, hence there is a necessary to investigate new biomarkers in LUAD progression. Competing endogenous RNA (ceRNA) network has been widely reported in the…
read more here.
Keywords:
lung adenocarcinoma;
mir 744;
luad;
proliferation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "OncoTargets and therapy"
DOI: 10.2147/ott.s258157
Abstract: Background Increasing investigations indicate that long noncoding RNA (lncRNA) is responsible for diverse biological functions during the progression of cancer. However, its functions and underlying mechanisms remain elusive. Here, we investigated the MAFG-AS1- expression profile…
read more here.
Keywords:
progression;
lasp1;
esophageal squamous;
mafg as1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Frontiers in Cell and Developmental Biology"
DOI: 10.3389/fcell.2021.688603
Abstract: Long non-coding RNAs (lncRNAs) have been shown to participate in the development and progression of several different types of cancer. Past studies indicated that lncRNA MAFG-antisense 1 (AS1) promotes colorectal cancer. However, the role of…
read more here.
Keywords:
drug;
mafg as1;
as1 promotes;
cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.856580
Abstract: Long Noncoding RNAs (LncRNAs) have recently been identified as key regulator in tumor progression. The LncRNA MAFG-AS1 has been reported to facilitate the progression of multiple cancers, however, its role in prostate cancer is still…
read more here.
Keywords:
progression;
prostate cancer;
cancer;
mafg as1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Surgery"
DOI: 10.3389/fsurg.2022.848831
Abstract: Purpose Long non-coding RNAs musculoaponeurotic fibrosarcoma oncogene family, protein G antisense 1 (lnc-MAFG-AS1) regulates hepatocellular carcinoma (HCC) progression and treatment resistance in multiple ways, while its engagement in HCC clinical management remains obscure. The current…
read more here.
Keywords:
tumor;
lnc mafg;
mafg;
mafg as1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "International Journal of Oncology"
DOI: 10.3892/ijo.2020.5150
Abstract: Long noncoding RNA (lncRNA) MAF BZIP transcription factor G antisense RNA 1 (MAFG-AS1) has been demonstrated to serve an important role in the progression of various types of cancer, whereas its role in breast cancer…
read more here.
Keywords:
cancer;
mir 150;
mafg as1;
breast cancer ... See more keywords